e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Immix Biopharma, Inc. - Common Stock (NQ:IMMX)

5.280 -0.230 (-4.17%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Immix Biopharma, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radar ↗

December 08, 2025

Market-based odds now show an 87% chance of a rate cut.

Via Stocktwits

Topics ETFs Economy Government

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 08, 2025

Via Benzinga

The trading volume of these stocks is deviating from the norm in today's session. ↗

May 29, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

May 27, 2025

Volume analysis on 2025-05-27: stocks with an unusual volume in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 23, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

May 23, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

May 23, 2025

As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 23, 2025

Via Benzinga

Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket ↗

May 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 22, 2025

Via Benzinga

Thursday's after hours session: top gainers and losers ↗

May 22, 2025

After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024 ↗

August 12, 2024

IMMX stock results show that Immix Biopharma beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

IMMX Stock Earnings: Immix Biopharma Beats EPS for Q1 2024 ↗

May 13, 2024

IMMX stock results show that Immix Biopharma beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

IMMX Stock Earnings: Immix Biopharma Misses EPS for Q4 2023 ↗

April 02, 2024

IMMX stock results show that Immix Biopharma missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 25, 2024

Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 25, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 23, 2023

Via Benzinga

What's Going On With Cancer-Focused Immix Biopharma Stock Today? ↗

October 02, 2023

Immix Biopharma Inc (NASDAQ: IMMX) announced the presentation of updated data from the ongoing Phase 1b/2 NEXICART-1 study of its NXC-201, an autologous, BCMA-targeted chimeric antigen receptor T

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

September 25, 2023

Via Benzinga

The 3 Best Speculative Stocks to Buy Now: September 2023 ↗

September 07, 2023

These best speculative stocks are the ones to buy in the long term for strong returns on your investment portfolio.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 26, 2023

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis ↗

May 22, 2023

Immix Biopharma Inc's (NASDAQ: IMMX) subsidiary Nexcella Inc announced updated AL Amyloidosis clinical data from its ongoing Phase 1b/2a NEXICART-1 study of its BCMA-targeted chimeric antigen receptor...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy